Earnings Feed
Start Free
Home/Insiders/LORD JONATHAN T MD
LJ
SEC Insider//CIK 0001112980

LORD JONATHAN T MD

CIK 00011129807 companiesLOUISVILLE, KY
SEC Profile

Transactions

50

Companies

7

Filings

13

CIK

0001112980

Recent Transactions

50 trades
  • Award
    BIOLASE, INC

    Restricted Stock Unit

    2023-06-08+721,154→ 779,901 total
  • Sale
    BIOLASE, INC

    Common Stock

    2022-12-07$0.75/sh−3,537→ 59,925 total
  • Award
    BIOLASE, INC

    Restricted Stock Unit

    2022-05-11+58,747→ 58,747 total
  • Disposition to Issuer
    BIOLASE, INC

    Series G Preferred Stock

    2022-04-28−1,395.41→ 0 total
  • Sale
    BIOLASE, INC

    Common Stock

    2021-12-15$0.38/sh−11,038→ 633,096 total
  • Award
    BIOLASE, INC

    Stock Appreciation Right

    2021-06-11+189,902→ 189,902 total
  • Award
    BIOLASE, INC

    Restricted Stock Unit

    2021-06-11+330,000→ 330,000 total
  • Award
    BIOLASE, INC

    Restricted Stock Unit

    2020-08-06+20,000→ 443,602 total
  • Award
    BIOLASE, INC

    Series F Convertible Preferred

    2020-07-22+6→ 6 total
  • Award
    BIOLASE, INC

    Warrants

    2020-07-22+15,000→ 15,000 total
  • Award
    BIOLASE, INC

    Restricted Stock Unit

    2020-05-13+291,178→ 423,602 total
  • Award
    BIOLASE, INC

    Stock Option (right to buy)

    2020-05-13+330,178→ 443,659 total
  • Award
    BIOLASE, INC

    Restricted Stock Unit

    2019-08-07+132,424→ 709,569 total
  • Purchase
    BIOLASE, INC

    Common Stock

    2018-11-16$1.36/sh+10,000→ 577,145 total
  • Purchase
    BIOLASE, INC

    Common Stock

    2018-08-14$1.45/sh+30,598→ 567,145 total
  • Purchase
    BIOLASE, INC

    Common Stock

    2018-08-10$1.25/sh+69,402→ 536,547 total
  • Award
    BIOLASE, INC

    Restricted Stock Unit

    2018-05-14+144,828→ 172,140 total
  • Award
    BIOLASE, INC

    Restricted Stock Unit

    2018-05-14+27,312→ 27,312 total
  • Exercise/Conversion
    BIOLASE, INC

    Restricted Stock Unit

    2018-05-11−7,042→ 0 total
  • Exercise/Conversion
    BIOLASE, INC

    Common Stock

    2018-05-11+7,042→ 100,470 total
  • Exercise of In-Money
    BIOLASE, INC

    Subscription Rights (Right to Buy)

    2017-12-05−100,000→ 0 total
  • Exercise of In-Money
    BIOLASE, INC

    Common Stock

    2017-12-05$0.46/sh+100,000→ 467,145 total
  • Award
    BIOLASE, INC

    Stock Option (right to buy)

    2017-11-08+19,737→ 578,131 total
  • Award
    BIOLASE, INC

    Stock Option (right to buy)

    2017-09-12+65,891→ 558,394 total
  • Award
    BIOLASE, INC

    Stock Option (right to buy)

    2017-09-11+65,385→ 492,503 total
  • Conversion
    BIOLASE, INC

    Common Stock

    2017-06-30$1.24/sh+76,800→ 430,490 total
  • Conversion
    BIOLASE, INC

    Series D Participating Convertible Preferred Stock

    2017-06-30−768→ 0 total
  • Award
    BIOLASE, INC

    Stock Option (right to buy)

    2017-05-10+105,634→ 427,118 total
  • Award
    BIOLASE, INC

    Restricted Stock Unit

    2017-05-10+35,211→ 35,211 total
  • Exercise/Conversion
    BIOLASE, INC

    Common Stock

    2017-05-08+50,000→ 353,690 total
  • Exercise/Conversion
    BIOLASE, INC

    Restricted Stock Unit

    2017-05-08−50,000→ 0 total
  • Purchase
    BIOLASE, INC

    Warrants (right to buy)

    2017-04-18$0.13/sh+37,387→ 37,387 total
  • Purchase
    BIOLASE, INC

    Series D Participating Convertible Preferred Stock

    2017-04-18$124.00/sh+768→ 768 total
  • Conversion
    BIOLASE, INC

    Series C Participating Convertible Preferred Stock

    2016-09-30−1,770→ 0 total
  • Conversion
    BIOLASE, INC

    Common Stock

    2016-09-30$1.13/sh+177,000→ 303,690 total
  • Sale
    DEXCOM INC$DXCM

    Common Stock

    2016-09-01$91.50/sh−10,000→ 52,820 total
  • Sale
    DEXCOM INC$DXCM

    Common Stock

    2016-08-12$90.50/sh−5,000→ 126,373 total
  • Sale
    DEXCOM INC$DXCM

    Common Stock

    2016-08-11$90.78/sh−5,000→ 131,373 total
  • Purchase
    BIOLASE, INC

    Warrants (right to buy)

    2016-08-01$0.13/sh+40,708→ 40,708 total
  • Purchase
    BIOLASE, INC

    Series C Participating Convertible Preferred Stock

    2016-08-01$113.00/sh+1,770→ 1,770 total
  • Award
    DEXCOM INC$DXCM

    Common Stock

    2016-05-25$0.00/sh+4,791→ 136,373 total
  • Award
    BIOLASE, INC

    Restricted Stock Unit

    2016-05-06+50,000→ 50,000 total
  • Award
    BIOLASE, INC

    Stock Option (right to buy)

    2016-05-06+120,152→ 293,739 total
  • Purchase
    BIOLASE, INC

    Common Stock, par value $0.001 per share

    2015-11-09$0.75/sh+16,310→ 126,690 total
  • Sale
    DEXCOM INC$DXCM

    Common Stock

    2015-09-09$90.96/sh−10,000→ 131,582 total
  • Exercise/Conversion
    BIOLASE, INC

    Restricted Stock Unit

    2015-08-27−9,217→ 0 total
  • Exercise/Conversion
    BIOLASE, INC

    Common Stock

    2015-08-27+9,217→ 110,380 total
  • Award
    DEXCOM INC$DXCM

    Common Stock

    2015-06-03$0.00/sh+4,475→ 141,582 total
  • Award
    BIOLASE, INC

    Stock Option (right to buy)

    2015-04-27+132,159→ 173,587 total
  • Sale
    DEXCOM INC$DXCM

    Common Stock

    2014-11-11$53.09/sh−18,058→ 137,107 total

Companies

7

Recent Filings

13

Address

HUMANA INC. 500 WEST MAIN STREET

LOUISVILLE, KY, 40202

View on SEC.gov